Neurology® Podcast
Eligibility for Anti-Amyloid Treatment
- Autor: Vários
- Narrador: Vários
- Editora: Podcast
- Duração: 0:23:27
- Mais informações
Informações:
Sinopse
Dr. Gregg Day talks with Dr. Vijay Ramanan about the clinical trial eligibility criteria for lecanemab treatment for participants with early Alzheimer disease and the generalizability of anti-amyloid treatment. Read the related article in Neurology. Visit NPub.org/Podcast for associated article links.
